Brian Lian - 01 May 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
01 May 2023
Net transactions value
-$1,010,250
Form type
4
Filing time
01 May 2023, 19:03:26 UTC
Previous filing
21 Apr 2023
Next filing
04 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Sale $1,010,250 -45,000 -2% $22.45 2,197,963 01 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.